Armistice Capital’s Intelligent Bio Solutions INBS Stock Holding History

Armistice Capital’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Buy	141,397 +11,397	+9%	+$30K	﹤0.01%	244
2026 Q1	$435K	Buy	+130,000	New	+$898K	0.01%	178

Other funds holding INBS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Armistice Capital's INBS Position: Q2 2026 in Review

Armistice Capital increased its Intelligent Bio Solutions (INBS) stake by 8.8% in Q2 2026, buying an estimated $30K and bringing the position to 141,397 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

Armistice Capital first reported a position in INBS in Q1 2026 and has held it in 2 quarters since. The position peaked at $435K in Q1 2026. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

Armistice Capital held 141,397 shares of Intelligent Bio Solutions worth $325K as of Q2 2026.
Armistice Capital bought 11,397 Intelligent Bio Solutions shares in Q2 2026, an estimated $30K.
Intelligent Bio Solutions made up ﹤0.01% of Armistice Capital's portfolio in Q2 2026, its #244 holding.
Armistice Capital first reported a position in Intelligent Bio Solutions in Q1 2026 and has held it in 2 quarters since.
Armistice Capital's Intelligent Bio Solutions position peaked at $435K in Q1 2026.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.